Barclays’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $2.07M | Buy |
|
|||||
|
2022
Q3 | $3.13M | Buy |
|
|||||
|
2022
Q2 | $335K | Buy |
|
|||||
|
2022
Q1 | $118K | Sell |
|
|||||
|
2021
Q4 | $1.76M | Buy |
|
|||||
|
2021
Q3 | $1.04M | Buy |
|
|||||
|
2021
Q2 | $410K | Sell |
|
|||||
|
2021
Q1 | $1.74M | Sell |
|
|||||
|
2020
Q4 | $2.26M | Sell |
|
|||||
|
2020
Q3 | $4M | Sell |
|
|||||
|
2020
Q2 | $2.41M | Buy |
|
|||||
|
2020
Q1 | $391K | Buy |
|
|||||
|
2019
Q4 | $716K | Buy |
|
|||||
|
2019
Q3 | $205K | Buy |
|
|||||
|
2019
Q2 | $201K | Buy |
|
|||||
|
2019
Q1 | $154K | Sell |
|
|||||
|
2018
Q4 | $249K | Buy |
|
|||||
|
2018
Q3 | $359K | Buy |
|
|||||
|
2018
Q2 | $267K | Sell |
|
|||||
|
2018
Q1 | $543K | Sell |
|
|||||
|
2017
Q4 | $419K | Buy |
|
|||||
|
2017
Q3 | $52K | Buy |
|
|||||
|
2017
Q2 | $54K | Buy |
|
|||||
|
2017
Q1 | $6K | Buy |
|
|||||
|
2016
Q4 | $3K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $6K | Buy |
|